Literature DB >> 22349606

Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders.

S Rathbun1, A Norris, J Stoner.   

Abstract

AIM: Endovenous foam sclerotherapy (EFS) is used widely throughout the USA for the treatment of venous disorders. The purpose of the quantitative meta-analysis was to systematically and comprehensively evaluate the literature to provide accurate estimates of safety and efficacy outcomes for this procedure.
METHODS: A comprehensive electronic search of published literature in several databases was performed using a wide variety of MESH headings. In addition, meeting abstracts and bibliographies of selected references were reviewed for eligible papers. Two reviewers abstracted selected treatment-related data.
RESULTS: Of 684 identified manuscripts and abstracts reviewed, 104 papers were abstracted and analysed. More than 50% were published between 2004 and 2008. EFS was found to be effective with similar vein occlusion rates to laser therapy, but less effective than surgery. In addition, major adverse effects were rare.
CONCLUSIONS: EFS is a safe and effective therapy for the treatment of venous disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349606     DOI: 10.1258/phleb.2011.011111

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  8 in total

1.  Optimal and safe treatment of spider leg veins measuring less than 1.5 mm on skin type IV patients, using repeated low-fluence Nd:YAG laser pulses after polidocanol injection.

Authors:  Javier Moreno-Moraga; Esteban Hernández; Josefina Royo; Justo Alcolea; M Jose Isarría; Mihail Lucian Pascu; Adriana Smarandache; Mario Trelles
Journal:  Lasers Med Sci       Date:  2012-08-11       Impact factor: 3.161

Review 2.  [Guidelines for sclerotherapy of varicose veins : S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version].

Authors:  E Rabe; F X Breu; I Flessenkämper; H Gerlach; S Guggenbichler; B Kahle; R Murena; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; S Werth; F Pannier
Journal:  Hautarzt       Date:  2021-01       Impact factor: 0.751

3.  Right heart transiting thrombi caused by endovenous sclerotherapy: the treatment is not consensual.

Authors:  Driss Laghlam; Sara Hamadouche; Raphael Dautry; Vincent Spagnoli
Journal:  BMJ Case Rep       Date:  2017-11-28

Review 4.  Injection sclerotherapy for varicose veins.

Authors:  Ricardo de Ávila Oliveira; Rachel Riera; Vladimir Vasconcelos; Jose Cc Baptista-Silva
Journal:  Cochrane Database Syst Rev       Date:  2021-12-10

Review 5.  S2k guidelines: diagnosis and treatment of varicose veins.

Authors:  F Pannier; T Noppeney; J Alm; F X Breu; G Bruning; I Flessenkämper; H Gerlach; K Hartmann; B Kahle; H Kluess; E Mendoza; D Mühlberger; A Mumme; H Nüllen; K Rass; S Reich-Schupke; D Stenger; M Stücker; C G Schmedt; T Schwarz; J Tesmann; J Teßarek; S Werth; E Valesky
Journal:  Hautarzt       Date:  2022-04-19       Impact factor: 1.198

6.  The effects of foam sclerotherapy on ulcer healing: a single-centre prospective study.

Authors:  G Cuffolo; E Hardy; J Perkins; L J Hands
Journal:  Ann R Coll Surg Engl       Date:  2019-01-03       Impact factor: 1.891

7.  Short Term Outcome of Adjunct Foam Sclerotherapy for Varicose Veins in Patients Subjected to RFA at Dhulikhel Hospital, Nepal.

Authors:  R M Karmacharya; B Shrestha; A Singh; N Chandi; N Bhandari
Journal:  Int J Vasc Med       Date:  2019-10-07

Review 8.  Sclerotherapy in the treatment of varicose veins : S2k guideline of the Deutsche Gesellschaft für Phlebologie (DGP) in cooperation with the following societies: DDG, DGA, DGG, BVP.

Authors:  E Rabe; F X Breu; I Flessenkämper; H Gerlach; S Guggenbichler; B Kahle; R Murena; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; S Werth; F Pannier
Journal:  Hautarzt       Date:  2021-12       Impact factor: 0.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.